KRAS and cancer: MD Anderson Cancer Center in Texas published their Arab patients’ data describing that KRAS/NRAS/BRAF prevalence were 44.4%, 4%, and 4%, respectively, compared to 48.4%, 4%, and 4%, respectively, in the matched Western population [18].